Corcept Therapeutics Incorporated (CORT)
NASDAQ: CORT · Real-Time Price · USD
51.40
+0.25 (0.49%)
At close: Dec 20, 2024, 4:00 PM
52.55
+1.15 (2.24%)
After-hours: Dec 20, 2024, 4:24 PM EST
Corcept Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for CORT stock have an average target of 75.25, with a low estimate of 67 and a high estimate of 80. The average target predicts an increase of 46.40% from the current stock price of 51.40.
Analyst Consensus: Strong Buy
* Price targets were last updated on Oct 31, 2024.
Analyst Ratings
The average analyst rating for CORT stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 1 | 1 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 5 | 5 | 4 | 4 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +55.64% | Oct 31, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $45 → $80 | Strong Buy | Maintains | $45 → $80 | +55.64% | Oct 18, 2024 |
Truist Securities | Truist Securities | Strong Buy Maintains $65 → $76 | Strong Buy | Maintains | $65 → $76 | +47.86% | Sep 30, 2024 |
Piper Sandler | Piper Sandler | Buy Maintains $38 → $67 | Buy | Maintains | $38 → $67 | +30.35% | Sep 18, 2024 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $38 → $78 | Strong Buy | Maintains | $38 → $78 | +51.75% | Jul 31, 2024 |
Financial Forecast
Revenue This Year
705.67M
from 482.38M
Increased by 46.29%
Revenue Next Year
826.28M
from 705.67M
Increased by 17.09%
EPS This Year
1.39
from 0.94
Increased by 47.57%
EPS Next Year
1.79
from 1.39
Increased by 28.77%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 735.6M | 920.2M | 1.5B | |||
Avg | 705.7M | 826.3M | 1.1B | |||
Low | 672.3M | 744.7M | 896.7M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 52.5% | 30.4% | 83.4% | |||
Avg | 46.3% | 17.1% | 38.0% | |||
Low | 39.4% | 5.5% | 8.5% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 1.51 | 2.10 | 5.57 | |||
Avg | 1.39 | 1.79 | 3.80 | |||
Low | 1.27 | 1.33 | 2.34 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 60.9% | 51.4% | 211.5% | |||
Avg | 47.6% | 28.8% | 112.8% | |||
Low | 35.5% | -3.9% | 31.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.